60% more content is being produced than 6 months ago in order to meet the needs of today’s more digitally focused sales and marketing teams.
For emerging pharma companies, it’s increasingly more important to establish the right content model early on to enable and sustain rapid content creation at scale. From creation, review and approval, to distribution and delivery, pharma companies need to understand how its assets will pass through each stage of the content lifecycle, and ultimately make its way to the hands of doctors and patients in the most efficient—and compliant—way possible.
Read the ebook to discover: